IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Elderly Patients (>65 Years)
Fondazione Italiana Linfomi - ETSmonoclonal_antibodyPhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 48/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Elderly Patients (>65 Years) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PREDNISONE TABLETS Fondazione Italiana Linfomi - ETS | Phase 3 | BB |
Inno-206 Fondazione Italiana Linfomi - ETS | Phase 3 | BB |
VINBLASTINE Fondazione Italiana Linfomi - ETS | Phase 3 | BB |
FILGRASTIM Fondazione Italiana Linfomi - ETS | Phase 3 | B |
Cyclophosphamide Fondazione Italiana Linfomi - ETS | Phase 3 | B |
Epirubicin Fondazione Italiana Linfomi - ETS | Phase 3 | B |
(+)-VINCRISTINE Fondazione Italiana Linfomi - ETS | Phase 3 | B |
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →